Immunological characteristics and T-cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T-cell-depleted autologous stem cell transplantation

Immunology

Volumn 142, Issue 2, 2014, Pages 227-236

  Wu, Qiong ^a   Pesenacker, Anne M ^a,f   Stansfield, Alka ^b   King, Douglas ^c   Barge, Dawn ^d   Foster, Helen E ^e   Abinun, Mario ^d,e   Wedderburn, Lucy R ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Cell Medica Ltd   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Autologous stem cell transplantation; Childhood arthritis; Immune reconstitution; T cell receptor repertoire clonal diversity

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; GLOBULIN; PREDNISOLONE; T LYMPHOCYTE RECEPTOR;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLONAL VARIATION; COMPLEMENTARITY DETERMINING REGION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REMISSION; STEM CELL TRANSPLANTATION; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CHILDHOOD ARTHRITIS; IMMUNE RECONSTITUTION; T-CELL RECEPTOR REPERTOIRE CLONAL DIVERSITY;

ARTHRITIS, JUVENILE; CHILD; CLONE CELLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; MALE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS;

EID: 84899109799     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12245     Document Type: Article

References (29)

1. Petty RE, Southwood TR, Manners P et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31:390-2.
2. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007; 369:767-78.
3. Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol 2011; 7:416-26.
4. Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford) 2002; 41:1428-35.
5. Abinun M, Flood TJ, Cant AJ et al. Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007). Mol Immunol 2009; 47:46-51.
6. + immune regulatory network. Blood 2006; 107:1696-702.
7. de Kleer IM, Brinkman DM, Ferster A et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004; 63:1318-26.
8. Wulffraat N, van Royen A, Bierings M, Vossen J, Kuis W. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999; 353:550-3.
9. Wulffraat NM, Brinkman D, Ferster A et al. Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. Bone Marrow Transplant 2003; 32(Suppl 1):S61-4.
10. Brinkman DM, de Kleer IM, ten Cate R et al. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Arthritis Rheum 2007; 56:2410-21.
11. Fassas A, Passweg JR, Anagnostopoulos A et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol 2002; 249:1088-97.
12. Burt RK, Georganas C, Schroeder J et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum 1999; 42:2281-5.
13. van Laar JM, Verburg RJ, Fibbe WE, Breedveld FC. Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience. J Rheumatol Suppl 2001; 64:25-7.
14. Song XN, Lv HY, Sun LX, Meng JB, Wang JK, Zhang JQ, Chang YJ. Autologous stem cell transplantation for systemic lupus erythematosus: report of efficacy and safety at 7 years of follow-up in 17 patients. Transplant Proc 2011; 43:1924-7.
15. Wedderburn LR, Abinun M, Palmer P, Foster HE. Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis. Arch Dis Child 2003; 88:201-5.
16. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005; 435:620-7.
17. Muraro PA, Douek DC, Packer A et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201:805-16.
18. Thiel A, Alexander T, Schmidt CA et al. Direct assessment of thymic reactivation after autologous stem cell transplantation. Acta Haematol 2008; 119:22-7.
19. Darlington PJ, Touil T, Doucet JS et al. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Ann Neurol 2013; 73:341-54.
20. + hematopoietic progenitors. Blood 1998; 91:2588-600.
21. + phenotype. Rheumatology (Oxford) 2001; 40:1299-307.
22. Koehne G, Zeller W, Stockschlaeder M, Zander AR. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19:149-56.
23. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A 1993; 90:4319-23.
24. Gorski J, Yassai M, Zhu X, Kissela B, Kissella B, Keever C, Flomenberg N. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 1994; 152:5109-19.
25. + T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 2003; 48:2001-10.
26. Prakken AB, van Eden W, Rijkers GT, Kuis W, Toebes EA, de Graeff-Meeder ER, van der Zee R, Zegers BJ. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996; 39:1826-32.
27. van Eden W, van der Zee R, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 2005; 5:318-30.
28. + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89:3700-7.
29. + regulatory T cells. Blood 2008; 111:5233-41.